Rosemary Mazanet, Director at Actinium Pharmaceuticals, Inc. (ATNM), bought 100 shares at $3.95 ($395) on 2013-05-15, disclosed to the SEC on 2013-05-22.
Open-market purchase of $395 ATNM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.